Minaris Regenerative Medicine’s leaders and experts are proud to share their knowledge and insight with the cell and gene therapy industry. Please review our current and past blog posts on topics of interest to this emerging industry.
At this year's Cell & Gene Meeting on the Mesa, Robert Preti, PhD, Chairman of the Alliance for Regenerative Medicine and President and CEO of Hitachi Chemical ...
Growing up, many of us became familiar with the children’s song, ‘The Bear went Over the Mountain’. In this nursery rhyme (of sorts) a bear that succeeds in scaling a ...
In November 2014, Japan passed a new regenerative medicine law, the upshot of which is that it enables therapeutic development sponsors to receive conditional marketing ...
Automation is not just a buzzword. Automation—the act of taking laborious, manual steps of cell therapy manufacturing and making them more efficient through elimination ...
ISCT hosted a webinar, titled "Building Deliverable Cell Therapeutics: A Methodical Approach to Manufacturing Development," featuring experts from PCT on October 22, ...
At the end of this month, two of my colleagues and I have the opportunity to speak at the IBC Life Sciences Cell Therapy Bioprocessing and Commercialization Conference ...
PCT experts Robert Shaw, VP, Commercial Development; Brian Hampson, VP Manufacturing Development & Engineering, and Candice Betz, Director of QA/QC, have recently ...
2012 marks the 20th anniversary of the formation of the International Society for Cellular Therapy (ISCT). ISCT was first conceived by a handful of pioneers at a ...